SciSparc Ltd.
Cannabinoid-based pharmaceutical molecules and formulations for central nervous system disorders
- Sector
- Biotech
- Headquarters
- TEL AVIV, L3
- Latest Form D
- $4.2M, Mar 2025
- Total capital
- $21.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $21.5M
- 5 Form D · last Mar 2025
- 20 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 3 pending · first 2021
- Rank in peer group#293 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$4.2M
- Private capital raisedForm D · SEC · 4th filing$5M
- Private capital raisedForm D · SEC · 3rd filing$10M
- Offering registeredForm D · SEC · 2nd filing$3.9M
- Private capital raisedForm D · SEC · 1st filing$2.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#293 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alon DayanDirectorNamed in SEC Form D filings
- Amitay WeissDirectorNamed in SEC Form D filings
- Amnon Ben ShayDirectorNamed in SEC Form D filings
- Dr. Adi Zuloff-ShaniExecutive OfficerNamed in SEC Form D filings
- Itschak ShremExecutive Officer, DirectorNamed in SEC Form D filings
- Liat SidiDirectorNamed in SEC Form D filings
Show all 9 people
- Lior ViderDirectorNamed in SEC Form D filings
- Moshe RevachDirectorNamed in SEC Form D filings
- Oz AdlerExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 7- GrantedCompositions And Methods Of Potentiating AntimicrobialsUSPTOUS 11,491,172
- PendingCompositions And Methods For Potentiating Derivatives Of 4-AMINOPHENOLSUSPTOApplication 17604801
- PendingCombinations Of Cannabinoids And N-acylethanolaminesUSPTOApplication 17524942
Show all 7 patent records
- Compositions And Methods Of Potentiating AntimicrobialsNov 8, 2022 · US 11,491,172Granted
- Compositions And Methods For Potentiating Derivatives Of 4-AMINOPHENOLSJul 7, 2022 · Application 17604801Pending
- Combinations Of Cannabinoids And N-acylethanolaminesMar 10, 2022 · Application 17524942Pending
- Combination Of Cannabinoids And N-acylethanolaminesFeb 1, 2022 · US 11,234,956Granted
- Combinations Of Cannabinoids And N-acylethanolaminesDec 28, 2021 · US 11,207,290Granted
- Combinations Of Cannabinoids And N-acylethanolaminesDec 14, 2021 · US 11,197,845Granted
- Combinations Of Cannabinoids And N-acylethanolaminesJan 30, 2020 · Application 16589611Pending
Related companies, and why
- Capra Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Skylark BioSimilar federal contract value in Biotech · null in contracts
- Lexaria Bioscience Corp.Similar federal contract value in Biotech · null in contracts
- Renovion, Inc.Similar federal contract value in Biotech · null in contracts
- Mestag TherapeuticsSimilar federal contract value in Biotech · null in contracts
- VASCULONICS INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .